Menu

Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Print

Papers on Alpha-1 research published in the COPD Foundation Journal

Wednesday, November 7, 2018
The latest issue of the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (Volume 5, Issue 4 – 2018) features papers from presenters at the “3rd Biennial International Research Conference on Alpha-1...
Divider

Mereo BioPharma and TAP work together in clinical study

Tuesday, November 6, 2018
Mereo BioPharma Group plc announced a collaboration with (and investment from) the venture philanthropy arm of the Alpha-1 Foundation, The Alpha-1 Project, Inc. (TAP) in Mereo’s MPH-966 development program. MPH-966 is an oral neutrophil...
Divider

Grifols affirms commitment to patients during Alpha-1 Awareness Month

Friday, November 2, 2018
November is Alpha-1 Awareness Month, and Grifols is proud to share its efforts to further increase Alpha-1 diagnosis rates and expand treatment options. Alpha-1 awareness matters. Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition...
Divider

Significant reduction in Alzheimer progression demonstrated

Thursday, November 1, 2018
Grifols (Spain) announced that the combination of Plasmapheresis, a well-known and safe procedure used in plasma exchange, with Albutein® 20% (Albumin - a safe, well tolerated plasma protein with multiple properties) has demonstrated a...
Divider

Alpha John Taylor passes away

Thursday, November 1, 2018
It is with a heavy heart that the Alpha-1 Foundation announces the passing of John Taylor, on September 29th, 2018. He was 60 years old. John led an incredible childhood in the town of Delran, New Jersey. He spread his wings and moved to...
Divider

November is Alpha-1 Awareness Month

Thursday, November 1, 2018
Miami, Nov. 1, 2018 – The month of November has been marked by the Alpha-1 Foundation as a month to raise awareness about Alpha-1 Antitrypsin Deficiency (Alpha-1), throughout several activities designed to increase knowledge and spread...
Divider

AlphaNet matches gift by the Cadwgan Family

Tuesday, October 30, 2018
On Thursday, October 25th, AlphaNet announced that they would match the $100,000 gift to the Alpha-1 Foundation that the Cadwgan Family has generously donated as a sign of gratefulness to Robert (Bob) Barrett’s years of service at AlphaNet....
Divider

Federal Health Insurance Exchange 2019 Open Enrollment

Tuesday, October 30, 2018
The Federal Health Insurance Exchange (also known as the Marketplace) Open Enrollment Period runs from November 1, 2018, to December 15, 2018, for coverage starting on January 1, 2019. Like last year, the Centers for Medicare & Medicaid...
Divider

Alpha-1 Foundation’s position and the Zemaira shortage

Monday, October 29, 2018
It has been brought to the attention of the Alpha-1 Foundation that CSL Behring has been experiencing delays in the distribution of Zemaira for several months now. The Foundation bases its knowledge of this situation solely on the information...
Divider

Improving plasma donations in California

Monday, October 29, 2018
A new law recently passed in the state of California, allowing trained individuals to perform a total protein test using a digital refractometer in plasma donation centers, which the Alpha-1 Foundation and other advocacy groups expect will lead to...
Divider

Karen Erickson to lead operations in TAP

Wednesday, October 24, 2018
The Alpha-1 Project (TAP) announces the appointment of Karen Erickson as Chief Operating Officer, a new position within TAP. The appointment is effective November 1, 2018. Erickson leaves her position as Associate Executive Director for...
Divider

Escape to the Cape was a total success for Alpha-1

Monday, October 22, 2018
A weekend in the scenic coast of Cape Cod, Massachusetts, with bike riding and lots of family fun was the perfect setting for this year’s Escape to the Cape Bike Trek, in which Team Alpha-1 raised $100,000 for Alpha-1 Antitrypsin Deficiency...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive